Med. praxi. 2021;18(2):88-91 | DOI: 10.36290/med.2021.014

The role of the general practitioner in the complex management of a patient with heart failure

MUDr. Renáta Aiglová, MUDr. Marie Lazárová, Ph.D.
I. interní klinika - kardiologická, Fakultní nemocnice Olomouc

Chronic heart failure is a major medical and socioeconomic problem. Patients with chronic heart failure are burdened by high morbidity and require systematic care, which includes repeated education of the regimen, gradual uptitration of therapy to the maximum tolerated doses, care for patients with mechanical cardiac support or palliative care. Repeated hospitalizations for heart failure significantly worsen the quality of life of patients, adversely affect their mortality and are also an economic burden on the health system. Given the growing prevalence of heart failure, cooperation at multiple levels of the health system, especially at the level of cardiologists and general practitioners, is essential for the provision of appropriate systematic care.

Keywords: heart failure, education, natriuretic peptides, therapy uptitration, mechanical cardiac support, palliative therapy.

Published: April 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Aiglová R, Lazárová M. The role of the general practitioner in the complex management of a patient with heart failure. Med. praxi. 2021;18(2):88-91. doi: 10.36290/med.2021.014.
Download citation

References

  1. Špinar J, et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor et Vasa 2016; 58: e530-e568. Go to original source...
  2. Lazárová M, Pavlů L. Možnosti optimalizace léčby chronického srdečního selhání. Kardiológia pre prax. 2016; 14(4): 201-203.
  3. Writing committee members, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240. Go to PubMed...
  4. Feltner C, Jones CD, Cené CW, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med 2014; 160: 774. Go to original source... Go to PubMed...
  5. Táborský M, Linhart A, Pyszko J, et al. Inhibitory sodíko-glukózového kotransportéru-2 při srdečním selhání: více než jen kontrola glykemie. Odborné stanovisko Asociace srdečního selhání Evropské kardiologické společnosti - souhrn dokumentu připravený ČKS. Cor et Vasa 2020; 62: 521-526. Go to original source...
  6. Táborský M, Linhart A, Rosolová H, Špinar J. Doporučené postupy ESC pro diabetes, prediabetes a kardiovaskulární onemocnění, vypracované ve spolupráci s EASD, 2019. Souhrn dokumentu připravený Českou kardiologickou společností. Cor et Vasa 2020; 62: 105-138. Go to original source...
  7. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418-1428. Go to original source... Go to PubMed...
  8. Phillips CO, Wright SM, Kern DE, et al. Conprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 2004; 291: 1358-1367. Go to original source... Go to PubMed...
  9. Juilliére Y, Jourdain P, Suty-Selton C, et al. Therapeutic patient education and all-cause mortality in patients with chronic heart failure: a propensity analysis. Int J of Cardiol. 2013; 168(1): 388-395. Go to original source... Go to PubMed...
  10. Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Proctice Guideline. J Card Fail 2010; 16: e1. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.